Approval · Notice of Compliance 6621 · 2005
BUSTAB: Notice of Compliance 6621
Issued April 26, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6621
- Date
- April 26, 2005
- Company
- Valeant Canada LpLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Anxiolytic
Products in this notice
Medicinal ingredients
- BUSPIRONE HCL 5 MG per TAB
- BUSPIRONE HCL 10 MG per TAB